The Antimicrobial Resistance Regulatory Strategy

Inhaltsverzeichnis (Table of Contents)

• Abstract
• Table of Contents
• Table of Figures
• Table of Tables
• Chapter 1. INTRODUCTION
• 1.1. Introduction
• 1.2. Background of the Research
• 1.3. Justification of the Research
• 1.4. Aims, Objectives and Scope of the Research
• 1.4.1. The Three Pillars
• 1.4.2. Strategy and Timelines
• 1.4.3. Summary
• 1.5. Outline of the Dissertation
• 1.6. Summary
• Chapter 2. LITERATURE REVIEW
• 2.1. Introduction
• 2.2. Antimicrobial History
• 2.2.1. Microbes and Diseases
• 2.2.2. Facing Resistance
• 2.2.3. Global Action Plan Overview
• 1.2. The European Union AMR Strategy
• 1.2.1. Regulatory Institutions and Organizations
• 1.2.2. The Antimicrobial Regulation in the EU
• 1.2.3. The EU Enforcement Against AMR
• 1.2.4. Summary
• 1.3. The United States AMR Approach
• 1.3.1. The US Legal Structure
• 1.3.2. The U.S. National Plan Outline
• 1.3.3. The US Enforcement Against AMR
• 1.3.4. Summary
• 1.4. Comparison of Strategy
• 1.4.1. National Policy
• 1.4.2. Antibiotic Stewardship
• 1.4.3. Incentives, Budgeting and Costing
• 1.4.4. Outside Aspects
• 1.4.5. Summary
• 1.5. Conclusions
• Chapter 2. METHODOLOGY
• 2.1. Introduction
• 2.2. Research Design
• 2.2.1. Choice of Research Methods
• 2.3. Population and Sampling
• 2.4. Data Collection
• 2.4.1. Questionnaires
• 2.4.2. Semi-structured Interviews
• 2.5. Data Analysis
• 2.6. Validity, Reliability and Bias
• 2.7. Ethics
• 2.8. Limitations
• 2.9. Summary
• 2.10. Conclusions
• Chapter 3. PRESENTATION AND ANALYSIS OF DATA
• 3.1. Introduction
• 3.2. Questionnaire Results
• 3.2.1. Awareness and Communication
• 3.2.2. Antibiotic Usage
• 3.2.3. Changes in Legislation
• 3.2.4. Summary
• 3.3. Interview Results
• 3.3.1. Regulatory Approaches
• 3.3.2. National Plan Implications
• 3.3.3. Challenges and Practicality
• 3.3.4. Out of Scope Aspects
• 3.3.5. Summary
• 3.4. Respondent's Recommendations
• 3.5. Conclusions
• Chapter 5. DISCUSSION
• 5.1. Introduction
• 5.2. Discussion
• 5.2.1. Findings in Relation to the Research Objectives
• 5.2.1.1. The EU and US Approaches on AMR (RO1)
• 5.2.1.2. Plan Implementation Impacts (RO2)
• 5.2.1.3. Challenges and Practicality (RO3)
• 5.2.1.4. Out of scope Aspects (RO4)
• 5.2.1.5. Summary of Findings
• 5.3. Key Conclusions
• 5.4. Limitations and Recommendations for Future Research
• 5.5. Research Reflexions
• 5.6. Final Conclusions

Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)

This dissertation investigates the practicality of implementing national action plans on antimicrobial resistance (AMR) in the EU and US regions. It analyzes the adoption process, identifies challenges, and explores out-of-scope issues. The research utilizes a phenomenological approach to understand the perspectives of stakeholders, including policy makers, pharmaceutical companies, healthcare providers, and patients.

• Antimicrobial Resistance and Its Global Impact
• National Action Plans for AMR in the EU and US
• Challenges and Practicalities of Implementing National Action Plans
• Stakeholder Engagement and Collaboration
• Incentivizing Research and Development of New Antibiotics

Zusammenfassung der Kapitel (Chapter Summaries)

• Chapter 1: Introduction

This chapter provides an overview of the research topic, outlining the background of AMR, the rationale for the study, and the research objectives. It also presents the dissertation's structure.

• Chapter 2: Literature Review

This chapter explores the history of antimicrobials, including the emergence of resistance, and the development of global action plans to address the issue. It examines the AMR strategies of the EU and US, focusing on their regulatory frameworks, enforcement mechanisms, and policy approaches.

• Chapter 2: Methodology

This chapter outlines the research methodology, including the research design, data collection methods, and data analysis techniques. It discusses the population and sampling strategies, ethical considerations, and limitations of the study.

• Chapter 3: Presentation and Analysis of Data

This chapter presents and analyzes the data collected from questionnaires and interviews, highlighting the findings on stakeholder awareness, antibiotic usage, legislative changes, and the implications of national action plans. It includes perspectives on regulatory approaches, challenges, and out-of-scope aspects.

Schlüsselwörter (Keywords)

The dissertation focuses on antimicrobial resistance, national action plans, regulatory strategy, One Health approach, stakeholder engagement, antibiotic stewardship, research and development, and the EU and US regions.

Frequently Asked Questions

What is the "One Health" approach?

It is an integrated approach that recognizes that the health of humans, animals, and the environment are closely linked, especially regarding antimicrobial resistance.

Why is there a lack of new antibiotic drug development?

A major paradox exists: because the use of antibiotics must be reduced to fight resistance, pharmaceutical companies have little financial incentive to invest in new ones.

What is the WHO Global Action Plan on AMR (GAP-AMR)?

It is a worldwide framework to combat antimicrobial resistance through national action plans, focusing on awareness, stewardship, and research.

How do the EU and US strategies against AMR differ?

While both follow GAP-AMR, they differ in regulatory pathways, enforcement mechanisms, and the specific legislative structures used to control antibiotic use.

What is "Antibiotic Stewardship"?

It refers to the systematic effort to improve the way antibiotics are prescribed and used to ensure they remain effective for future generations.